The research conducted by GME predicted that the Global Viral Inactivation Market will grow at a high CAGR value from 2021 to 2026. The method of viral inactivation has been designed to cater to the safety of the therapeutics products during the processing and production stage. The safe drug administration, development of vaccines, and blood products require the viral inactivation method to ensure the non-contaminated processing of such products.
Browse 159 Market Data Tables and 119 Figures
spread through 189 Pages and in-depth TOC on "Viral Inactivation Market - Forecast to 2026"
https://www.globalmarketestimates.com/market-report/global-viral-inactivation-market-2833
By Method
(Solvent Detergent Method, Pasteurization, Other Viral Inactivation Method), By
Product (Kits & Reagents, Services, Viral Inactivation Systems
&Accessories), By Application (Blood & Blood Products, Cellular &
Gene Therapy Products, Stem Cell Products, Tissue& Tissue Products,
Vaccines, and Therapeutics), By End User (Pharmaceutical and Biotechnology
Companies, Contract Research Organizations, Academic Research Institutes, Other
End Users) By Region (North America, Asia Pacific, Europe, Central & South
America, Middle East & Africa); End-User Landscape, Company Market Share
Analysis, and Competitor Analysis
Key Market Insights
·
The solvent detergent technique would occupy a
dominant space in this market.
·
Kits and reagents
will serve as a useful product in the market space owing to the product’s
rising importance in the inactivation of the novel SARS-Cov-2 virus.
·
Merck KGaA, Pall, Thermo Fisher
Scientific, Sartorius, Bio Reliance, Clean Cells, Charles River, GE Healthcare,
Rapid Labs, Bharat Biotech, and Danaher
Corporation are key players operating in this market
·
Browse the Report @ https://www.globalmarketestimates.com/market-report/global-viral-inactivation-market-2833
Method Outlook (Revenue, USD Billion,
2021-2026)
·
Solvent Detergent Method
·
Pasteurization
·
Other Viral Inactivation Method
Product Outlook (Revenue, USD Billion,
2021-2026)
·
Kits & Reagents
·
Services
·
Viral Inactivation Systems &Accessories
Application Outlook (Revenue, USD Billion,
2021-2026)
·
Blood & Blood Products
·
Cellular & Gene Therapy Products
·
Stem Cell Products
·
Tissue& Tissue Products
·
Vaccines and Therapeutics
End-User Outlook (Revenue, USD Billion,
2021-2026)
·
Pharmaceutical and Biotechnology Companies
·
Contract Research Organizations
·
Academic Research Institutes
·
Other End Users
Regional Outlook
(Revenue, USD Billion, 2021-2026)
North America
- The U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Rest of APAC
Central
& South America
- Brazil
- Argentina
- Rest of CSA
Middle
East & Africa
- Saudi Arabia
- UAE
- Rest of MEA
Contact:
Tracy Simon
Email address: tracy.simon@globalmarketestimates.com
Phone
Number: +16026667238
Website:
https://www.globalmarketestimates.com/
No comments:
Post a Comment